Panel Discussion: Evaluating the Cell vs Bispecific Evolution to Elevate Their Respective Advantages
Time: 10:00 am
day: Day 1
Details:
• Consolidating the clinical advances for both approaches while highlighting the next generation for each method
• Comparing clinical efficacy and safety data to highlight benefits and challenges of each modality
• Discussing how the impact of various targets and TCR enhancements may differ for each approach to determine priorities for future modification
• Reflecting on where each modality thrives and how they can learn from each other to further advance the TCR-based
therapy field
